Fig. 6From: Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patientsFlow chart of tested diagnostic and prognostic biomarkers in the two studied cohorts of patientsBack to article page